Literature DB >> 7592605

Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro.

H Dyhr-Mikkelsen1, J Kjems.   

Abstract

Continuous replication of human immunodeficiency virus type I (HIV-1) requires balanced expression of spliced and nonspliced mRNAs in the cytoplasm. This process is regulated post-transcriptionally by the viral-encoded Rev protein. An important prerequisite for Rev responsiveness is the presence of weak splice sites in the viral mRNA. We have investigated the splicing of the second intron of the HIV-1 Tat/Rev transcript in vitro and show that the 3'-splice site region is responsible for the inefficient splicing of the HIV-1 transcript. In contrast, the HIV-1 5'-splice site is highly functional in combination with a heterologous 3'-splice site. Incubation of the HIV-1 transcript in nuclear extract leads to a rapid accumulation of 50 S nonproductive pre-spliceosome complexes. These complexes contain mainly U1 and U2 small nuclear ribonucleoproteins and are formed independently of the presence of the downstream 3'-splice site. The HIV-1 transcripts, which do proceed through the first splicing step, utilize primarily a uridine as the branch acceptor nucleotide. Sequence comparison with other HIV-1 introns suggests that nucleotides other than adenosines are commonly used as branch points in these viruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592605     DOI: 10.1074/jbc.270.41.24060

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

2.  Crystal structure of a model branchpoint-U2 snRNA duplex containing bulged adenosines.

Authors:  J A Berglund; M Rosbash; S C Schultz
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

3.  Three recognition events at the branch-site adenine.

Authors:  C C Query; S A Strobel; P A Sharp
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

4.  Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.

Authors:  Z Si; B A Amendt; C M Stoltzfus
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

5.  Characterizing HIV-1 Splicing by Using Next-Generation Sequencing.

Authors:  Ann Emery; Shuntai Zhou; Elizabeth Pollom; Ronald Swanstrom
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

6.  Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.

Authors:  K Verhoef; P S Bilodeau; J L van Wamel; J Kjems; C M Stoltzfus; B Berkhout
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.

Authors:  Anna Tranell; Eva Maria Fenyö; Stefan Schwartz
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

8.  Human genomic sequences that inhibit splicing.

Authors:  W G Fairbrother; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

9.  The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.

Authors:  Z H Si; D Rauch; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor.

Authors:  Truus E M Abbink; Ben Berkhout
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.